{"id":"https://openalex.org/W4400042940","doi":"https://doi.org/10.21873/anticanres.17096","title":"PEMF Potentiates Doxorubicin-induced Late G2Arrest in MDA-MB-231 Breast Cancer Cells","display_name":"PEMF Potentiates Doxorubicin-induced Late G2Arrest in MDA-MB-231 Breast Cancer Cells","publication_year":2024,"publication_date":"2024-06-26","ids":{"openalex":"https://openalex.org/W4400042940","doi":"https://doi.org/10.21873/anticanres.17096","pmid":"https://pubmed.ncbi.nlm.nih.gov/38925852"},"language":"en","primary_location":{"id":"doi:10.21873/anticanres.17096","doi":"https://doi.org/10.21873/anticanres.17096","is_oa":false,"landing_page_url":"https://doi.org/10.21873/anticanres.17096","pdf_url":null,"source":{"id":"https://openalex.org/S157347057","display_name":"Anticancer Research","issn_l":"0250-7005","issn":["0250-7005","1791-7530"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4320800545","host_organization_name":"International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts","host_organization_lineage":["https://openalex.org/P4320800545"],"host_organization_lineage_names":["International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009572651","display_name":"Sung-Hun Woo","orcid":"https://orcid.org/0000-0002-1642-9341","observed_orcids":["https://orcid.org/0000-0002-1642-9341"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4405258769","display_name":"Yonsei University Mirae Campus","ror":"https://ror.org/0160gc229","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966","https://openalex.org/I4405258769"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"SUNG-HUN WOO","raw_affiliation_strings":["Department of Biomedical Laboratory Science, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Laboratory Science, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4405258769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022181614","display_name":"Byung Chul Jung","orcid":"https://orcid.org/0000-0003-0732-0122","observed_orcids":["https://orcid.org/0000-0003-0732-0122"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4405258769","display_name":"Yonsei University Mirae Campus","ror":"https://ror.org/0160gc229","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966","https://openalex.org/I4405258769"]},{"id":"https://openalex.org/I95457486","display_name":"University of California, Berkeley","ror":"https://ror.org/01an7q238","country_code":"US","type":"education","lineage":["https://openalex.org/I95457486"]}],"countries":["KR","US"],"is_corresponding":false,"raw_author_name":"BYUNG CHUL JUNG","raw_affiliation_strings":["Department of Biomedical Laboratory Science, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea","Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Laboratory Science, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4405258769"]},{"raw_affiliation_string":"Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, U.S.A","institution_ids":["https://openalex.org/I95457486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087807105","display_name":"JUN-YOUNG KIM","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4405258769","display_name":"Yonsei University Mirae Campus","ror":"https://ror.org/0160gc229","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966","https://openalex.org/I4405258769"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"JUN-YOUNG KIM","raw_affiliation_strings":["Department of Biomedical Engineering, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4405258769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074404938","display_name":"YONG-HEUM LEE","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4405258769","display_name":"Yonsei University Mirae Campus","ror":"https://ror.org/0160gc229","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966","https://openalex.org/I4405258769"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"YONG-HEUM LEE","raw_affiliation_strings":["Department of Biomedical Engineering, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea koaim@yonsei.ac.kr","Department of Biomedical Engineering, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea koaim@yonsei.ac.kr","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4405258769"]},{"raw_affiliation_string":"Department of Biomedical Engineering, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4405258769"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011795054","display_name":"Yoon Suk Kim","orcid":"https://orcid.org/0000-0002-1956-0126","observed_orcids":["https://orcid.org/0000-0002-1956-0126"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4405258769","display_name":"Yonsei University Mirae Campus","ror":"https://ror.org/0160gc229","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966","https://openalex.org/I4405258769"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"YOON SUK KIM","raw_affiliation_strings":["Department of Biomedical Laboratory Science, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea; yoonsukkim@yonsei.ac.kr","Department of Biomedical Laboratory Science, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Laboratory Science, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea; yoonsukkim@yonsei.ac.kr","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4405258769"]},{"raw_affiliation_string":"Department of Biomedical Laboratory Science, College of Software and Digital Healthcare Convergence, Yonsei University, Wonju, Republic of Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4405258769"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6474,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.58430286,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"44","issue":"7","first_page":"2837","last_page":"2846"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10874","display_name":"Electromagnetic Fields and Biological Effects","score":0.8779000043869019,"subfield":{"id":"https://openalex.org/subfields/1304","display_name":"Biophysics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10874","display_name":"Electromagnetic Fields and Biological Effects","score":0.8779000043869019,"subfield":{"id":"https://openalex.org/subfields/1304","display_name":"Biophysics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12976","display_name":"Magnetic and Electromagnetic Effects","score":0.09510000050067902,"subfield":{"id":"https://openalex.org/subfields/1102","display_name":"Agronomy and Crop Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pulsed-electromagnetic-fields","display_name":"pulsed electromagnetic fields","score":0.9959999918937683},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9340000152587891},{"id":"https://openalex.org/keywords/mda-mb-231-cells","display_name":"MDA-MB-231 cells","score":0.9879999756813049},{"id":"https://openalex.org/keywords/cdk1","display_name":"CDK1","score":0.9200000166893005},{"id":"https://openalex.org/keywords/myt1","display_name":"Myt1","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cdc25c","display_name":"Cdc25C","score":0.9150000214576721},{"id":"https://openalex.org/keywords/14-3-3-sigma","display_name":"14-3-3 sigma","score":0.9639999866485596},{"id":"https://openalex.org/keywords/topoisomerase-ii-alpha","display_name":"TOP2A","score":0.9649999737739563},{"id":"https://openalex.org/keywords/dna-damage","display_name":"DNA damage","score":0.7730000019073486},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5860000252723694},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.675000011920929}],"concepts":[{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.8365675806999207},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.550216555595398},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.5244417786598206},{"id":"https://openalex.org/C2780070996","wikidata":"https://www.wikidata.org/wiki/Q61482373","display_name":"Trypan blue","level":3,"score":0.5102682113647461},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4594358801841736},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.4427306056022644},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4377298355102539},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3964756727218628},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38384586572647095},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30557429790496826},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.29432493448257446},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17568495869636536},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1634322702884674},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09002402424812317}],"mesh":[{"descriptor_ui":"D000075223","descriptor_name":"Poly-ADP-Ribose Binding Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D004250","descriptor_name":"DNA Topoisomerases, Type II","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004574","descriptor_name":"Electromagnetic Fields","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020687","descriptor_name":"cdc25 Phosphatases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051357","descriptor_name":"Cyclin-Dependent Kinase 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D059565","descriptor_name":"G2 Phase Cell Cycle Checkpoints","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D059565","descriptor_name":"G2 Phase Cell Cycle Checkpoints","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.21873/anticanres.17096","doi":"https://doi.org/10.21873/anticanres.17096","is_oa":false,"landing_page_url":"https://doi.org/10.21873/anticanres.17096","pdf_url":null,"source":{"id":"https://openalex.org/S157347057","display_name":"Anticancer Research","issn_l":"0250-7005","issn":["0250-7005","1791-7530"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4320800545","host_organization_name":"International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts","host_organization_lineage":["https://openalex.org/P4320800545"],"host_organization_lineage_names":["International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer Research","raw_type":"journal-article"},{"id":"pmid:38925852","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38925852","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393315105","https://openalex.org/W7214621539","https://openalex.org/W7166508528","https://openalex.org/W4415616725","https://openalex.org/W2575016111","https://openalex.org/W4404500481","https://openalex.org/W1549717894","https://openalex.org/W221157846","https://openalex.org/W4399216235","https://openalex.org/W2002905825"],"abstract_inverted_index":{"Background/Aim:":[0],"Pulsed":[1],"electromagnetic":[2],"field":[3],"(PEMF)":[4],"stimulation":[5,33,55,179,237],"enhances":[6],"the":[7,29,35,40,51,57,96,185,197,233,243],"efficacy":[8,36],"of":[9,23,31,37,53,60,111,164,199,235,246],"several":[10],"anticancer":[11,16,58],"drugs.":[12],"Doxorubicin":[13],"is":[14],"an":[15,109,239],"drug":[17],"used":[18],"to":[19,49,77,241],"treat":[20],"various":[21],"types":[22],"cancer,":[24],"including":[25],"breast":[26,65,249],"cancer.":[27],"However,":[28],"effect":[30,52,245],"PEMF":[32,54,103,167,178,216,236],"on":[34,56,248],"doxorubicin":[38,61,165,176,247],"and":[39,69,75,132,154,166,212],"underlying":[41],"mechanisms":[42,141],"remain":[43],"unclear.":[44],"Thus,":[45],"this":[46],"study":[47],"aimed":[48],"investigate":[50],"activity":[59,195],"in":[62,143,184],"MDA-MB-231":[63,71,158],"human":[64],"cancer":[66,250],"cells.":[67,251],"Materials":[68],"Methods:":[70],"cells":[72,83,97,159],"were":[73,84,98,147],"seeded":[74],"allowed":[76],"incubate":[78],"for":[79,92,117],"48":[80,93,120],"h.":[81,94,121],"The":[82],"treated":[85,160,174],"with":[86,100,161,175],"doxorubicin,":[87],"cisplatin,":[88],"5-fluorouracil,":[89],"or":[90,119],"paclitaxel":[91],"Subsequently,":[95],"stimulated":[99],"a":[101,106,150,162],"60-min":[102],"session":[104],"thrice":[105],"day":[107],"(with":[108],"interval":[110],"4":[112],"h":[113],"between":[114],"each":[115],"session)":[116],"24":[118],"Cell":[122],"viability":[123,171],"was":[124,135],"assessed":[125],"by":[126,137,149,189,222],"trypan":[127],"blue":[128],"dye":[129],"exclusion":[130],"assay":[131,153],"cell-cycle":[133,182],"analysis":[134],"analyzed":[136],"flow":[138],"cytometry.":[139],"Molecular":[140],"involved":[142],"late":[144,186],"G2":[145,187],"arrest":[146,183],"confirmed":[148],"western":[151],"blot":[152],"confocal":[155],"microscopy.":[156],"Results:":[157],"combination":[163],"had":[168],"remarkably":[169],"lower":[170],"than":[172],"those":[173],"alone.":[177],"increased":[180,218],"doxorubicin-induced":[181,219],"phase":[188],"suppressing":[190],"cyclin-dependent":[191],"kinase":[192],"1":[193,203],"(CDK1)":[194],"through":[196],"enhancement":[198],"myelin":[200],"transcription":[201],"factor":[202],"(MYT1)":[204],"expression,":[205],"cell":[206],"division":[207],"cycle":[208],"25C":[209],"(CDC25C)":[210],"phosphorylation,":[211],"stratifin":[213],"(14-3-3\u03c3)":[214],"expression.":[215],"also":[217],"DNA":[220,224],"damage":[221],"inhibiting":[223],"topoisomerase":[225],"II":[226],"alpha":[227],"(TOP2A).":[228],"Conclusion:":[229],"These":[230],"findings":[231],"support":[232],"use":[234],"as":[238],"adjuvant":[240],"strengthen":[242],"antiproliferative":[244]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2024-06-27T00:00:00"}